Evidence, Pricing, and Access Strategy
Starting with informed pricing assumptions at an early stage of product development is key to commercial success.
Setting, and achieving, the right price for your product can be challenging. Many variables come into play, and it is important to identify which ones are most relevant in any given situation.
We work across all stages of a product’s development, using the most suitable approach and research methodologies.
Navigating complex issues
Determining an appropriate price can be complex. In some cases, there may be no pricing benchmark at all – for example, a brand-new therapy with no direct competitors, or launching into an emerging market.
In other cases, the product may have novel dosing features or be used across several indications.
Products used across multiple positions in a treatment pathway may face different reimbursement levels.
Reference pricing across major global markets means the right launch sequence is critical – and can determine commercial success or failure.
How we stand out
We tailor our approach to your specific needs and get up to speed quickly by drawing on the depth and breadth of our existing expertise.
We focus on applying the best methods to address the key issues for your product. We commit to delivering a clear, concise and comprehensive pricing strategy in agreed timeframes.
Our approaches to pricing strategy developing include:
Desk research based on internal payer expertise
Qualitative research based on interviews with external payers
National or international payer Advisory Boards
Preliminary health economic modelling
Semi-quantitative pricing research with clinicians
Evaluation of potential risk-sharing arrangements
